VC firm ORI Capital uses AI to fight cancer and other large-scale diseases

Ng Qi Siang
Ng Qi Siang 3/19/2021 06:31 AM GMT+08  • 9 min read
VC firm ORI Capital uses AI to fight cancer and other large-scale diseases
Even as AI takes over the healthcare industry, the human touch remains essential to saving lives.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The best ideas often emerge from the lowest moments in one’s life. For former Goldman Sachs Asia managing director Simone Song, that was when she was lying flat on a hospital bed in 2015, waiting for a colon tumour biopsy. In what turned out to be a life-changing resolution, she vowed to dedicate the rest of her life to fighting major diseases, if she could be cancer-free.

To be sure, Medical research and biotechnology are not exactly foreign territory for Song. Both of her parents were biotechnology pioneers in China, with her father being a member of the prestigious Chinese Academy of Sciences, the highest scientific body in the People’s Republic. Her mother invented China’s first biotechnology drug with global intellectual rights. Both of them also had an entrepreneurial bent, starting companies to bring their research to market.

Despite growing up in such a scholarly environment — her cousin even did a PhD under her mother before going to Harvard for post-doctoral studies — Song instead decided to enter investment banking, taking charge of Goldman Sachs’ investment banking business in greater China for healthcare. But surviving the removal of 15cm of her intestines convinced her to join the family trade. No longer a banker, she would instead be a soldier fighting on the frontlines against disease.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now